Literature DB >> 6305189

Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies.

R F Mueller, S Hornung, C E Furlong, J Anderson, E R Giblett, A G Motulsky.   

Abstract

Plasma paraoxonase hydrolyzes paraoxon, the principal metabolite of the insecticide parathione. A genetic polymorphism for enzyme activity has been previously demonstrated. We describe a new assay based on the differential inhibition by EDTA of plasma paraoxonase from persons with the high-activity allele (PX*H) that suggests a trimodality of activity levels in population studies. The gene frequency of the low activity allele (PX*L) in 531 Seattle blood donors of European origin was .7207. Family studies were consistent with codominant autosomal inheritance of two alleles, PX*L (low) and PX*H (high), coding for products with different activity levels. Biochemical measurements of sera from presumed homozygotes for the two different alleles revealed minor physicochemical differences suggestive of a structural difference between the allelic products. No evidence for linkage of the paraoxonase locus with any of 19 polymorphic markers would be detected.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305189      PMCID: PMC1685632     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  Genetic polymorphism and interethnic variability of plasma paroxonase activity.

Authors:  J R Playfer; L C Eze; M F Bullen; D A Evans
Journal:  J Med Genet       Date:  1976-10       Impact factor: 6.318

2.  Paraoxon-induced myopathy: muscle specificity and acetylcholine involvement.

Authors:  L Wecker; W D Dettbarn
Journal:  Exp Neurol       Date:  1976-05       Impact factor: 5.330

3.  Organophosphate splitting serum enzymes in different mammals.

Authors:  R Zech; K Zürcher
Journal:  Comp Biochem Physiol B       Date:  1974-07-15

4.  Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies.

Authors:  J Ott
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

Review 5.  Metabolism of insecticides in plants and animals.

Authors:  T R Fukuto; R L Metcalf
Journal:  Ann N Y Acad Sci       Date:  1969       Impact factor: 5.691

6.  Chronic inhibition of cholinesterase as a cause of myopathy.

Authors:  G M Fenichel; W B Kibler; W H Olson; W D Dettbarn
Journal:  Neurology       Date:  1972-10       Impact factor: 9.910

7.  [Enzymatic hydrolysis of diethyl-p-nitrophenylphosphate (E 600) by human serum].

Authors:  K Krisch
Journal:  Z Klin Chem Klin Biochem       Date:  1968-01

8.  [Differences in the reaction of human serum cholinesterases with E 600 (0,0-diethyl-0-(p-nitrophenyl)-phosphate)].

Authors:  U Rabast; H H Lindorf
Journal:  Arch Toxikol       Date:  1969

9.  Hydrolysis of diethyl-p-nitrophenylphosphate and ethyl-p-nitrophenylethylphosphonate by human sera.

Authors:  M Skrinjarić-Spoljar; E Reiner
Journal:  Biochim Biophys Acta       Date:  1968-09-03

10.  Poisoning with organophosphorus insecticides.

Authors:  W J Taylor; W Kalow; E A Sellers
Journal:  Can Med Assoc J       Date:  1965-10-30       Impact factor: 8.262

View more
  27 in total

1.  Regulatory effects of dioxin-like and non-dioxin-like PCBs and other AhR ligands on the antioxidant enzymes paraoxonase 1/2/3.

Authors:  Hua Shen; Larry W Robertson; Gabriele Ludewig
Journal:  Environ Sci Pollut Res Int       Date:  2015-05-27       Impact factor: 4.223

Review 2.  The human serum paraoxonase/arylesterase polymorphism.

Authors:  B N La Du
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

3.  Ecogenetic studies in Atacameño Indians.

Authors:  H W Goedde; F Rothhammer; H G Benkmann; P Bogdanski
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin.

Authors:  J Ortigoza-Ferado; R J Richter; S K Hornung; A G Motulsky; C E Furlong
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

5.  Paraoxonase 1 (PON1) status and substrate hydrolysis.

Authors:  Rebecca J Richter; Gail P Jarvik; Clement E Furlong
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-13       Impact factor: 4.219

Review 6.  Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.

Authors:  Lucio G Costa; Gennaro Giordano; Toby B Cole; Judit Marsillach; Clement E Furlong
Journal:  Toxicology       Date:  2012-07-31       Impact factor: 4.221

7.  Pediatric acute lymphoblastic leukemia and exposure to pesticides.

Authors:  Offie P Soldin; Hala Nsouli-Maktabi; Hala Nsouly-Maktabi; Jeanine M Genkinger; Christopher A Loffredo; Juan Antonio Ortega-Garcia; Drew Colantino; Dana B Barr; Naomi L Luban; Aziza T Shad; David Nelson
Journal:  Ther Drug Monit       Date:  2009-08       Impact factor: 3.681

8.  Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure.

Authors:  Pei-Chen Lee; Shannon L Rhodes; Janet S Sinsheimer; Jeff Bronstein; Beate Ritz
Journal:  Environ Int       Date:  2013-04-16       Impact factor: 9.621

9.  Cytogenetic effects of paraoxon and methyl-parathion on cultured human lymphocytes: SCE, clastogenic activity and cell cycle delay.

Authors:  S Singh; B Lehmann-Grube; H W Goedde
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015

10.  Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners?

Authors:  Kimberly A Davis; J Allen Crow; Howard W Chambers; Edward C Meek; Janice E Chambers
Journal:  Environ Health Perspect       Date:  2009-03-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.